Search Result

Results for "

VP

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Androgen Receptor (1) Antibiotic (15) Apoptosis (7) Arenavirus (3) Autophagy (5) Bacterial (18) Biochemical Assay Reagents (3) CDK (1) DNA/RNA Synthesis (5) Drug Metabolite (2) Endogenous Metabolite (9) Enterovirus (14) Environmental Pollutants (2) Filovirus (1) GnRH Receptor (2) GSK-3 (2) HDAC (1) Isotope-Labeled Compounds (7) Ligands for E3 Ligase (1) Ligands for Target Protein for PROTAC (1) Mitophagy (5) mRNA (1) Nucleoside Antimetabolite/Analog (3) Orthopoxvirus (7) Phosphodiesterase (PDE) (2) Phosphoramidites (1) PROTACs (1) Reactive Oxygen Species (ROS) (1) Reference Standards (8) RSV (1) Small Interfering RNA (siRNA) (4) Target Protein Ligand-Linker Conjugates (1) Tau Protein (1) TNF Receptor (1) Topoisomerase (6) Vasopressin Receptor (4) Virus Protease (1)
By Research Areas:	Cancer (9) Cardiovascular Disease (5) Infection (40) Inflammation/Immunology (4) Metabolic Disease (3) Neurological Disease (6)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) mRNA (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (2) Uracil (1) Phosphoramidites (1) siRNAs (4)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-13629

Etoposide Maximum Cited Publications 173 Publications Verification VP-16; VP-16-213	Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic	Infection Cancer
Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-14805

Tecovirimat 1 Publications Verification ST-246	Orthopoxvirus Arenavirus	Infection
Tecovirimat (ST-246) is an orally bioavailable and selective compound against orthopoxviruses including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses. Tecovirimat is evaluated against vaccinia, cowpox virus, ectromelia virus with EC₅₀ values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat targets the orthopoxvirus protein *VP37* which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus .

HY-19952

Pleconaril 1 Publications Verification VP 63843; Win 63843	Enterovirus	Infection
Pleconaril is a picornavirus capsid binding inhibitor that prevents attachment and/or virus uncoating. Pleconaril has potential for use in rhinoviruses and enteroviruses research .

HY-401424

Cremophor EL-36 Polyoxyethylene(36) Castor Oil; PEG-36 Castor Oil	Environmental Pollutants Biochemical Assay Reagents	Others
Cremophor EL-36 is a non-ionic surfactant, mainly used as a solubilizing carrier for poorly soluble Paclitaxel (HY-B0015). For example, Cremophor EL-36 can enhance the intracellular influx of Etoposide (HY-13629) without affecting drug efflux, and can dose-dependently increase the accumulation of VP-16 in lung adenocarcinoma cells (such as PC-14 and A549), significantly enhancing its cytotoxic effect .

HY-112258

IMP-1088 5+ Cited Publications	DNA/RNA Synthesis	Infection
IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC₅₀s of <1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K_d of <210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus virus-encoded protein (VP0) N-myristoylation. IMP-1088 protects host cells from the cytotoxic effects of viral infection .

HY-B0502

Enrofloxacin 15+ Cited Publications BAY VP 2674; PD160788	Bacterial Antibiotic Orthopoxvirus	Infection
Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC₉₀ of 0.312 μg/mL for Mycoplasma bovis.

HY-W019940

2-Methoxy-4-vinylphenol	Environmental Pollutants Endogenous Metabolite	Inflammation/Immunology
2-Methoxy-4-vinylphenol (2M4VP), a naturally Germination inhibitor, exerts potent anti-inflammatory effects .

HY-19350

BML-210 2 Publications Verification	HDAC Apoptosis	Cancer
BML-210 is a potent HDAC inhibitor. BML-210 can inhibit the HDAC4-VP16-driven reporter signal with an apparent IC₅₀ of ∼5 µM. BML-210 has a specific disruptive effect on the HDAC4:MEF2 interaction. BML-210 causes an increase in the G0/G1 phase. BML-210 induces apoptosis and displays antitumour activities in orthotopic mammary tumours in mice .

HY-W019806

Lacto-N-fucopentaose I LNFP I	Endogenous Metabolite CDK Reactive Oxygen Species (ROS) Apoptosis Enterovirus Bacterial	Infection Inflammation/Immunology
Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development .

HY-128879A

VP3.15 dihydrobromide	Phosphodiesterase (PDE) GSK-3 Tau Protein	Cardiovascular Disease Neurological Disease Inflammation/Immunology
VP3.15 dihydrobromide is a highly potent, orally bioavailable, and CNS-penetrant PDE7-GSK3 dual inhibitor, with IC₅₀ values of 1.59 μM and 0.88 μM against PDE7 and GSK3, respectively . VP3.15 dihydrobromide elevates intracellular cAMP levels, suppresses immune responses, enhances remyelination, limits excessive tau phosphorylation, and alleviates neuroinflammation and neuronal loss. VP3.15 dihydrobromide promotes oligodendrocyte precursor cell differentiation, improves in vivo remyelination, inhibits autoimmune encephalomyelitis, and mitigates germinal matrix-intraventricular hemorrhage-related brain injury, cerebral atrophy, ventricular enlargement, and cognitive impairment. VP3.15 dihydrobromide can be used in research related to multiple sclerosis and germinal matrix-intraventricular hemorrhage .

HY-B0502A

Enrofloxacin monohydrochloride 15+ Cited Publications BAY VP 2674 monohydrochloride; PD160788 monohydrochloride	Bacterial Antibiotic Orthopoxvirus	Infection
Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC₉₀ of 0.312 μg/mL for Mycoplasma bovis. Enrofloxacin monohydrochloride shows inhibitory activity against vaccinia virus (VV).

HY-N2036

Mosloflavone 1 Publications Verification	TNF Receptor Enterovirus Bacterial	Infection
Mosloflavone is a flavonoid isolated from Scutellaria baicalensis Georgi with ?anti-EV71 activity. Mosloflavone? inhibits VP2 virus replication and protein expression during the initial stage of virus infection and inhibits viral VP2 capsid protein synthesis. Mosloflavone is a promising biocide and inhibits P. aeruginosa virulence and biofilm formation.

HY-13629R

Etoposide (Standard) 1 Publications Verification VP-16 (Standard); VP-16-213 (Standard)	Reference Standards Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic	Infection Cancer
Etoposide (Standard) is the analytical standard of Etoposide. This product is intended for research and analytical applications. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-W012017

2-Hydroxytetradecanoic acid	Enterovirus	Infection
2-Hydroxytetradecanoic acid is a hydroxy fatty acid that inhibits cleavage between the enterovirus capsid proteins VP4 and VP2. 2-Hydroxytetradecanoic Acid has anti-virus activity .

HY-P0056A

Histrelin acetate	GnRH Receptor	Cancer
Histrelin acetate, a GnRH analogue, is a GnRH Receptor agonist. Histrelin acetate increases serum luteinising hormone (LH), follicle stimulating hormone (FSH) and testosterone levels. Histrelin acetate can be used in the research of prostate cancer, endometriosis .

HY-W019940R

2-Methoxy-4-vinylphenol (Standard)	Reference Standards Endogenous Metabolite	Inflammation/Immunology
2-Methoxy-4-vinylphenol (Standard) is the analytical standard of 2-Methoxy-4-vinylphenol. This product is intended for research and analytical applications. 2-Methoxy-4-vinylphenol (2M4VP), a naturally Germination inhibitor, exerts potent anti-inflammatory effects .

HY-154585

VP-U-6	Nucleoside Antimetabolite/Analog	Others
VP-U-6 is a nucleoside analog that can be used in oligonucleotide synthesis .

HY-P1163A

D[LEU4,LYS8]-VP TFA	Vasopressin Receptor	Cardiovascular Disease Neurological Disease
D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V_1b receptor, with the K_is of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V_1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities .

HY-133813A

Apovincaminic acid hydrochloride salt	Drug Metabolite	Neurological Disease
Apovincaminic acid hydrochloride salt is an orally active and brain-penetrant main active metabolite of Vinpocetine (VP). Apovincaminic acid hydrochloride salt exerts a neuroprotective type of action .

HY-12994

VP-14637 MDT-637	RSV	Infection
MDT-637 (VP 14637) is a novel respiratory syncytial virus (RSV) fusion inhibitor with an IC₅₀ of 1.42 ng/mL.

HY-B0502R

Enrofloxacin (Standard) BAY VP 2674 (Standard); PD160788 (Standard)	Reference Standards Bacterial Antibiotic Endogenous Metabolite Orthopoxvirus	Infection
Enrofloxacin (Standard) is the analytical standard of Enrofloxacin. This product is intended for research and analytical applications. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-14805A

Tecovirimat monohydrate 1 Publications Verification ST-246 monohydrate	Orthopoxvirus Arenavirus	Infection
Tecovirimat (ST-246) monohydrate is the monohydrate form of Tecovirimat (HY-14805). Tecovirimat monohydrate is an orally bioavailable and selective compound against orthopoxviruses [including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses]. Tecovirimat monohydrate is evaluated against vaccinia, cowpox virus, ectromelia virus with EC₅₀ values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat monohydrate targets the orthopoxvirus protein *VP37* which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat monohydrate exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus. Tecovirimat monohydrate could be used in the study for orthopoxvirus-induced diseases .

HY-P0056

Histrelin	GnRH Receptor	Cancer
Histrelin, a GnRH analogue, is a GnRH Receptor agonist. Histrelin increases serum luteinising hormone (LH), follicle stimulating hormone (FSH) and testosterone levels. Histrelin can be used in the research of prostate cancer, endometriosis .

HY-111233

Disoxaril WIN-51711	Enterovirus	Infection
Disoxaril (WIN-51711) is an antivirus agent with activity against poliovirus types 1 and 2. Disoxaril inserts into the hydrophobic interior of virus capsid protein VP1 to stabilize virion conformation, inhibits poliovirus uncoating, and prevents viral RNA release and synthesis. Disoxaril can be used for the research of poliovirus infection .

HY-128879

VP3.15	Phosphodiesterase (PDE) GSK-3	Neurological Disease
VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC₅₀s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS) .

HY-W881465

5'(E)-VP-2'-OMe-U phosphoramidite	Nucleoside Antimetabolite/Analog Phosphoramidites	Metabolic Disease
5'(E)-VP-2'-OMe-U Phosphoramidite is a monomeric raw material that can be used for nucleic acid synthesis.

HY-B0502S

Enrofloxacin-d5 BAY VP 2674-d₅; PD160788-d₅	Bacterial Antibiotic Endogenous Metabolite	Infection
Enrofloxacin-d₅ is the deuterium labeled Enrofloxacin. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-113761

ASN03576800	Filovirus	Infection
ASN03576800 could be a potent inhibitor for Ebola virus matrix protein *VP40* in process of viral assembly and budding process. ASN03576800 occupies the RNA binding region of VP40 .

HY-122046

Amb123203	Endogenous Metabolite	Infection
Amb123203 is an antiviral compound with the activity of inhibiting viral budding. Amb123203 exerts its effect by blocking the interaction between mVP40 and Nedd4 proteins. Amb123203 has a significant inhibitory effect on the budding of VP40 virus-like particles (VLPs) of Marburg (MARV) and Ebola viruses. Amb123203 can effectively target RNA viruses that rely on the PPxY L domain for efficient budding, showing broad-spectrum antiviral activity. The discovery of Amb123203 provides an important basis for the development of new broad-spectrum antiviral compounds .

HY-14805S

Tecovirimat-d4 ST-246-d₄	Isotope-Labeled Compounds Orthopoxvirus Arenavirus	Infection
Tecovirimat-d₄ (ST-246-d₄) is a deuterium-labelled Tecovirimat (HY-14805). Tecovirimat is an orally bioavailable and selective compound against orthopoxviruses [including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses]. Tecovirimat is evaluated against vaccinia, cowpox virus, ectromelia virus with EC₅₀ values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat targets the orthopoxvirus protein *VP37* which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus. Tecovirimat could be used in the study for orthopoxvirus-induced diseases .

HY-CE01868

VP-CoA VP-Coenzyme A; Valproyl-CoA; Valproyl-coenzyme A	Biochemical Assay Reagents	Metabolic Disease
VP-CoA (VP-Coenzyme A) is a coenzyme A derivative .

HY-W744243

Etoposide-d4 VP-16-d₄; VP-16-213-d₄	Isotope-Labeled Compounds Apoptosis Topoisomerase Bacterial Autophagy Mitophagy Antibiotic	Cancer
Etoposide-d₄ (VP-16-d₄; VP-16-213-d₄) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-W1119957

5'-VP-2'-OMe-U phosphoramidite	Biochemical Assay Reagents	Others
5'-VP-2'-OMe-U phosphoramidite is a phosphoramidite that contains 5’ DMT and uridine with 2’-O-methyl protection. 5'-VP-2'-OMe-U Phosphoramidite can be used to synthesize oligonucleotide.

HY-P1163

D[LEU4,LYS8]-VP	Vasopressin Receptor	Cardiovascular Disease Neurological Disease
D[LEU4,LYS8]-VP is a selective agonist of vasopressin V_1b receptor, with the K_is of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V_1b receptor, respectively. D[LEU4,LYS8]-VP has weak antidiuretic, vasopressor, and in vitro oxytocic activities .

HY-W881466

5'(E)-VP-2'-OMe-Bz-A Phosphoramidite	DNA/RNA Synthesis	Others
5'(E)-VP-2'-OMe-Bz-A Phosphoramidite is a phosphoramidate nucleotide precursor compound, which is mainly used to synthesize stable and functionalized modified oligonucleotides and is used in the development and synthesis of nucleic acid drugs .

HY-P991153

Potravitug	Virus Protease	Infection
Potravitug is a humanized immunoglobulin G1-κ monoclonal antibody targeting the major capsid protein VP1 of BK polyomavirus (BKV). Potravitug is promising for research of BKV-infection-related diseases, such as BKV-induced nephropathy after organ transplantation .

HY-145850

EV-A71-IN-1	Enterovirus	Infection
EV-A71-IN-1 is a human enterovirus A71 (EV-A71) capsid protein inhibitor with an EC₅₀ of 0.27 μM against EV-A71. EV-A71-IN-1 is a capsid binder that blocks the interaction between the viral VP1 and the host receptor hSCARB2. EV-A71-IN-1 inhibits a series of different human enteroviruses without significant cytotoxicity (CC₅₀>56.2 μM) .

HY-115965R

VP-4604 (Standard)	Reference Standards Bacterial Antibiotic	Infection
VP-4604 (Standard) is the analytical standard of VP-4604. This product is intended for research and analytical applications. VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) agent. VP-4604 exhibits significant microbial growth inhibition toward Staphylococcus aureus (ATCC 43300) with MIC of 4-8 μg/mL. VP-4604 inhibits the growth of methicillin‐resistant Staphylococcus aureus with growth inhibition >95%[1].

HY-115965

VP-4604	Bacterial Antibiotic	Infection
VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) agent. VP-4604 exhibits significant microbial growth inhibition toward Staphylococcus aureus (ATCC 43300) with MIC of 4-8 µg/mL. VP-4604 inhibits the growth of methicillin‐resistant Staphylococcus aureus with growth inhibition >95% .

HY-115964

VP-4556	Bacterial Antibiotic	Infection
VP-4556 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) agent. VP-4556 exhibits significant microbial growth inhibition toward Staphylococcus aureus (ATCC 43300) with MIC of 8 µg/mL. VP-4556 inhibits the growth of methicillin‐resistant Staphylococcus aureus with growth inhibition >95% .

HY-W024297

VP-4509	Bacterial	Infection
VP-4509, an anti-methicillin‐resistant Staphylococcus aureus (MRSA) agent, with the MIC of 49.3 µM. VP-4509 also possesses high antibacterial activity towards gram-negative bacteria P. aeruginosa .

HY-13629S

Etoposide-d3 VP-16-d₃; VP-16-213-d₃	Isotope-Labeled Compounds Topoisomerase Antibiotic Apoptosis Bacterial Autophagy Mitophagy	Infection Cancer
Etoposide-d3 (VP-16-d3) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-13629S1

Etoposide-13C,d3 VP-16-¹³C,d₃; VP-16-213-¹³C,d₃	Isotope-Labeled Compounds Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic	Infection Cancer
Etoposide- ¹³C,d₃ is the ¹³C- and deuterium labeled Etoposide. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-403188

5'(E)-VP-2'-OMe-Bz-C Phosphoramidite	DNA/RNA Synthesis	Others
5'(E)-VP-2'-OMe-Bz-C Phosphoramidite is a phosphoramidite monomer used in nucleic acid synthesis, such as oligonucleotides.

HY-106122

NK-611 VP 19	Topoisomerase DNA/RNA Synthesis	Cancer
NK-611 (VP 19) is an epipodophyllotoxin derivative. NK-611 induces DNA double-strand breaks by inhibiting topoisomerase II (IC₅₀ = 56 μM). NK-611 does not inhibit microtubule polymerization, thus avoiding the side effects of the parent compound, Podofilox (HY-15552). NK-611 exhibits broad-spectrum antitumor activity and demonstrates potent efficacy in in vivo models of leukemia. NK-611 can be used in cancer research .

HY-B0502AR

Enrofloxacin monohydrochloride (Standard) BAY VP 2674 monohydrochloride (Standard); PD160788 monohydrochloride (Standard)	Reference Standards Bacterial Antibiotic Endogenous Metabolite Orthopoxvirus	Infection
Enrofloxacin (monohydrochloride) (Standard) is the analytical standard of Enrofloxacin (monohydrochloride). This product is intended for research and analytical applications. Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis. Enrofloxacin monohydrochloride shows inhibitory activity against vaccinia virus (VV).

HY-B0502AS

Enrofloxacin-d5 hydrochloride BAY VP 2674-d5 hydrochloride; PD160788-d5 hydrochloride	Isotope-Labeled Compounds Bacterial Antibiotic Endogenous Metabolite	Infection
Enrofloxacin-d₅ (hydrochloride) is deuterium labeled Enrofloxacin (monohydrochloride). Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-B0502AS1

Enrofloxacin-d5 hydriodide BAY VP 2674-d5 hydriodide; PD160788-d5 hydriodide	Isotope-Labeled Compounds Bacterial Antibiotic Endogenous Metabolite	Infection
Enrofloxacin-d₅ (hydriodide) is the deuterium labeled Enrofloxacin (monohydrochloride). Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-RS16746

Avp Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Avp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Avp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Avp Mouse Pre-designed siRNA Set A Avp Mouse Pre-designed siRNA Set A

HY-W012017R

2-Hydroxytetradecanoic acid (Standard)	Reference Standards Enterovirus	Infection
2-Hydroxytetradecanoic acid is a hydroxy fatty acid that inhibits cleavage between the enterovirus capsid proteins VP4 and VP2. 2-Hydroxytetradecanoic Acid has anti-virus activity .

Cat. No.	Product Name	Type

HY-401424

Cremophor EL-36

Polyoxyethylene(36) Castor Oil; PEG-36 Castor Oil

Biochemical Assay Reagents

Cremophor EL-36 is a non-ionic surfactant, mainly used as a solubilizing carrier for poorly soluble Paclitaxel (HY-B0015). For example, Cremophor EL-36 can enhance the intracellular influx of Etoposide (HY-13629) without affecting drug efflux, and can dose-dependently increase the accumulation of VP-16 in lung adenocarcinoma cells (such as PC-14 and A549), significantly enhancing its cytotoxic effect .

Cat. No.	Product Name	Target	Research Area	Image

HY-P99438

Anivovetmab KIND-030	Inhibitory Antibodies	Infection
Anivovetmab (KIND-030) is an anti-VP2 protein (canine parvovirus major capsid protein) monoclonal antibody (IgG2 isotype). Anivovetmab has the potential for studying canine parvovirus infection .

HY-P991153

Potravitug	Virus Protease	Infection
Potravitug is a humanized immunoglobulin G1-κ monoclonal antibody targeting the major capsid protein VP1 of BK polyomavirus (BKV). Potravitug is promising for research of BKV-infection-related diseases, such as BKV-induced nephropathy after organ transplantation .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-13629

Etoposide Maximum Cited Publications 173 Publications Verification VP-16; VP-16-213	Infection Monophenols Classification of Application Fields Sinopodophyllum hexandrum (Royle) Ying Lignans Phenols Phenylpropanoids Plants Berberidaceae Disease Research Fields Source Classification	Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic
Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-W019940

2-Methoxy-4-vinylphenol	Structural Classification Monophenols Classification of Application Fields Brassica oleracea L. Phenols Plants Brassicaceae Inflammation/Immunology Disease Research Fields Source Classification	Environmental Pollutants Endogenous Metabolite
2-Methoxy-4-vinylphenol (2M4VP), a naturally Germination inhibitor, exerts potent anti-inflammatory effects .

HY-W019806

Lacto-N-fucopentaose I LNFP I	Infection Structural Classification Polysaccharides Animals Classification of Application Fields Inflammation/Immunology Disease Research Fields Saccharides	Endogenous Metabolite CDK Reactive Oxygen Species (ROS) Apoptosis Enterovirus Bacterial
Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development .

HY-N2036

Mosloflavone 1 Publications Verification	Infection Monophenols Flavonoids Classification of Application Fields Flavones Labiatae Phenols Plants Medicago truncatula Gaertn. Disease Research Fields Source Classification	TNF Receptor Enterovirus Bacterial
Mosloflavone is a flavonoid isolated from Scutellaria baicalensis Georgi with ?anti-EV71 activity. Mosloflavone? inhibits VP2 virus replication and protein expression during the initial stage of virus infection and inhibits viral VP2 capsid protein synthesis. Mosloflavone is a promising biocide and inhibits P. aeruginosa virulence and biofilm formation.

HY-13629R

Etoposide (Standard) 1 Publications Verification VP-16 (Standard); VP-16-213 (Standard)	Structural Classification Monophenols Sinopodophyllum hexandrum (Royle) Ying Lignans Phenols Phenylpropanoids Plants Berberidaceae Source Classification	Reference Standards Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic
Etoposide (Standard) is the analytical standard of Etoposide. This product is intended for research and analytical applications. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-W019940R

2-Methoxy-4-vinylphenol (Standard)	Monophenols Microorganisms Brassica oleracea L. Phenols Plants Brassicaceae Source Classification	Reference Standards Endogenous Metabolite
2-Methoxy-4-vinylphenol (Standard) is the analytical standard of 2-Methoxy-4-vinylphenol. This product is intended for research and analytical applications. 2-Methoxy-4-vinylphenol (2M4VP), a naturally Germination inhibitor, exerts potent anti-inflammatory effects .

HY-B0502R

Enrofloxacin (Standard) BAY VP 2674 (Standard); PD160788 (Standard)	Structural Classification Natural Products Endogenous metabolite Source Classification	Reference Standards Bacterial Antibiotic Endogenous Metabolite Orthopoxvirus
Enrofloxacin (Standard) is the analytical standard of Enrofloxacin. This product is intended for research and analytical applications. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-B0502AR

Enrofloxacin monohydrochloride (Standard) BAY VP 2674 monohydrochloride (Standard); PD160788 monohydrochloride (Standard)	Structural Classification Natural Products Endogenous metabolite Source Classification	Reference Standards Bacterial Antibiotic Endogenous Metabolite Orthopoxvirus
Enrofloxacin (monohydrochloride) (Standard) is the analytical standard of Enrofloxacin (monohydrochloride). This product is intended for research and analytical applications. Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis. Enrofloxacin monohydrochloride shows inhibitory activity against vaccinia virus (VV).

HY-N16775

Gylongiposide I	Triterpenes Structural Classification Terpenoids Cucurbitaceae Plants Gynostemma pentaphyllum (Thunb.) Makino Source Classification	Enterovirus
Gylongiposide I is a selective inhibitor against the enterovirus EV71 with an EC₅₀ of 1.53 μM. Gylongiposide I exerts antiviral activity by reducing viral protein VP1 expression and viral genomic RNA levels. Gylongiposide I can be used in the development of anti-EV71 drugs related to hand, foot and mouth disease .

Species:	Virus (18)
Tag:	His (13) Tag Free (1) Myc (1) GST (1) MBP (2) Fc (4)
Source:	sf9 insect cells (1) Sf9 insect cells (8) E. coli (9)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P702060

	VP40 Protein, Zaire ebolavirus (H269L) VP40; Matrix protein VP40; Ebola VP40; eVP40; Membrane-associated protein VP40	Virus	E. coli
	The VP40 protein is critical in viral assembly and interacts with viral ribonucleocapsid and host ESCRT proteins (VPS4, PDCD6IP/ALIX, NEDD4, TSG101). It promotes efficient budding and binds to the host E3 ubiquitin ligase SMURF2. VP40 Protein, Zaire ebolavirus (H269L) is the recombinant Virus-derived VP40 protein, expressed by E. coli , with tag free.

HY-P704198

	Zaire ebolavirus VP30 Protein (His) VP30; Minor nucleoprotein VP30; EbolaVP30; eVP30; Transcription activator VP30	Virus	E. coli
	Zaire ebolavirus VP30 Protein (His) is the recombinant virus-derived Zaire ebolavirus VP30 protein, expressed by E. coli, with N-6*His tag.

HY-P75720

	Ebola virus VP40/Matrix VP40 Protein (Q5XX06, His) Ebola virus EBOV (subtype Sudan, strain Gulu) VP40 / Matrix protein VP40 Protein (His)	Virus	E. coli
	Ebola virus VP40 (matrix VP40 protein) centrally directs virus assembly and budding and has complex interactions with viral ribonucleocapsid and host ESCRT proteins (VPS4, PDCD6IP/ALIX, NEDD4, TGS101). Ebola virus VP40/Matrix VP40 Protein (Q5XX06, His) is the recombinant Virus-derived Ebola virus VP40/Matrix VP40 protein, expressed by E. coli , with N-His labeled tag.

HY-P75719

	Ebola virus VP40/Matrix VP40 Protein (YP_138522, His-MBP) Ebola virus EBOV (subtype Sudan, strain Gulu) VP40 / Matrix protein VP40 Protein (His-MBP)	Virus	E. coli
	Ebola virus VP40 (matrix VP40 protein) centrally directs virus assembly and budding and has complex interactions with viral ribonucleocapsid and host ESCRT proteins (VPS4, PDCD6IP/ALIX, NEDD4, TGS101). Ebola virus VP40/Matrix VP40 Protein (YP_138522, His-MBP) is the recombinant Virus-derived Ebola virus VP40/Matrix VP40 protein, expressed by E. coli , with N-His, N-MBP labeled tag.

HY-P75716

	Ebola virus VP40/Matrix VP40 Protein (B8XCM9, His) Ebola virus EBOV (subtype Bundibugyo, strain Uganda 2007) VP40 / Matrix protein VP40 Protein (His)	Virus	E. coli
	Ebola virus VP40/Matrix VP40 Protein is essential for assembling and budding virus particles, interacting with host proteins linked to the multivesicular body pathway. Ebola virus VP40/Matrix VP40 Protein (B8XCM9, His) is the recombinant Virus-derived Ebola virus VP40/Matrix VP40 protein, expressed by E. coli , with N-His labeled tag.

HY-P76309

	Ebola virus VP24 Protein (YP_003815439, His) Ebola virus EBOV (subtype Bundibugyo, strain Uganda 2007) VP24 Protein; VP24 Protein; EBOV	Virus	E. coli
	Ebola virus VP24 Protein (YP_003815439, His) is the recombinant Virus-derived Ebola virus VP24 protein, expressed by E. coli, with N-His labeled tag.

HY-P72302A

	Intermediate capsid protein VP6, Rotavirus A (sf9, His) Intermediate capsid protein VP6	Virus	Sf9 insect cells
	The intermediate capsid protein VP6 self-assembles into an icosahedral capsid with T=13 symmetry, forming the middle layer of the virus particle. It contains 230 VP6 trimers that protect dsRNA and prevent host cell antiviral responses. Intermediate capsid protein VP6, Rotavirus A (sf9, His) is the recombinant Virus-derived Intermediate capsid protein VP6, expressed by Sf9 insect cells , with N-His, C-Myc labeled tag.

HY-P75723

	Ebola virus VP40/Matrix VP40 Protein (AHX24648, His-MBP) Ebola virus EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) VP40 / Matrix protein VP40 Protein (His-MBP)	Virus	E. coli
	Ebola virus VP40 (matrix VP40 protein) centrally directs virus assembly and budding and has complex interactions with viral ribonucleocapsid and host ESCRT proteins (VPS4, PDCD6IP/ALIX, NEDD4, TGS101).Ebola virus VP40/Matrix VP40 Protein (AHX24648, His-MBP) is the recombinant Virus-derived Ebola virus VP40/Matrix VP40 protein, expressed by E.coli , with N-His, N-MBP labeled tag.

HY-P72302

	Intermediate capsid protein VP6, Rotavirus A (sf9, His, Myc) Intermediate capsid protein VP6	Virus	Sf9 insect cells
	The intermediate capsid protein VP6 self-assembles into an icosahedral capsid with T=13 symmetry, forming the middle layer of the virus particle. It contains 230 VP6 trimers that protect dsRNA and prevent host cell antiviral responses. Intermediate capsid protein VP6, Rotavirus A (sf9, His, myc ) is the recombinant Virus-derived Intermediate capsid protein VP6, expressed by Sf9 insect cells , with N-His, C-Myc labeled tag.

HY-P72307

	Major capsid protein VP1 Protein, Murine polyomavirus (sf9, His) Major structural protein VP1	Virus	Sf9 insect cells
	The major capsid protein, the VP1 protein, is a 40 nm diameter icosahedral capsid composed of 72 pentamers linked by disulfide bonds. During infection, VP1 participates in nucleosome rearrangement and encapsulates replicated genomic DNA. Major capsid protein VP1 Protein, Murine polyomavirus (sf9, His) is the recombinant Virus-derived Major capsid protein VP1 protein, expressed by sf9 insect cells , with C-His labeled tag.

HY-P76280

	Coxsackievirus A16 VP1 Protein (295a.a, sf9, Fc) Coxsackievirus A16 (Cox A16) (strain G-10) VP4 Protein; VP1 Protein; CV	Virus	Sf9 insect cells
	Coxsackievirus A16 (CVA16) can cause hand-foot-and-mouth disease (HFMD). CVA16 is a small, non-enveloped, icosahedral particle containing a single-stranded, positive-sense viral RNA genome of approximately 7.4 kb in length. CVA16 can be cleaved by viral proteases into 4 structural (VP1 to VP4) and 7 nonstructural (2A to 2C, and 3A to 3D) proteins. CVA16 interacts with its host receptors (cell surface heparan sulfate glycosaminoglycans and SCARB2 as its uncoating receptor) to enter into susceptible cells. Upon binding, CVA16 mature virions may transform to an uncoating intermediate state. Coxsackievirus A16 VP1 Protein is one of the capsid subunit protein of cleaved CVA16. Coxsackievirus A16 VP1 Protein (295a.a, sf9, Fc) is the recombinant Virus-derived Coxsackievirus A16 VP1 protein, expressed by Sf9 insect cells , with C-hFc labeled tag.

HY-P76281

	Coxsackievirus A16 VP4 Protein (68a.a, sf9, Fc) Coxsackievirus A16 (Cox A16) (strain G-10) VP4 Protein; VP4 Protein; CV	Virus	Sf9 insect cells
	Coxsackievirus A16 (CVA16) can cause hand-foot-and-mouth disease (HFMD). CVA16 is a small, non-enveloped, icosahedral particle containing a single-stranded, positive-sense viral RNA genome of approximately 7.4 kb in length. CVA16 can be cleaved by viral proteases into 4 structural (VP1 to VP4) and 7 nonstructural (2A to 2C, and 3A to 3D) proteins. CVA16 interacts with its host receptors (cell surface heparan sulfate glycosaminoglycans and SCARB2 as its uncoating receptor) to enter into susceptible cells. Upon binding, CVA16 mature virions may transform to an uncoating intermediate state. Coxsackievirus A16 VP1 Protein is one of the capsid subunit protein of cleaved CVA16. Coxsackievirus A16 VP4 Protein (68a.a, sf9, Fc) is the recombinant Virus-derived Coxsackievirus A16 VP4 protein, expressed by Sf9 insect cells , with C-rFc labeled tag.

HY-P76310

	Ebola virus VP24 Protein (AHX24653, His) Ebola virus EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) VP24 Protein; VP24 Protein; EBOV	Virus	E. coli
	Ebola virus VP24 Protein is an IFN antagonist, and mediates nucleocapsid assembly. VP24 inhibits IFN-activated signaling by preventing nuclear import of STAT1 via competitive binding to nuclear import receptors (karyopherins). VP24 can interact with NP and is essential for nucleocapsid formation and packaging into the virion. Ebola virus VP24 Protein (AHX24653, His) is the recombinant Virus-derived Ebola virus VP24 protein, expressed by E. coli , with N-His labeled tag.

HY-P76891

	Ebola virus VP40/Matrix VP40 Protein (AHX24648, His) Ebola virus EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Matrix protein VP40 Protein (His)	Virus	E. coli
	Ebola virus VP40 (matrix VP40 protein) centrally directs virus assembly and budding and has complex interactions with viral ribonucleocapsid and host ESCRT proteins (VPS4, PDCD6IP/ALIX, NEDD4, TGS101). Ebola virus VP40/Matrix VP40 Protein (AHX24648, His) is the recombinant Virus-derived Ebola virus VP40/Matrix VP40 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P75250

	Enterovirus D68 VP4 Protein (sf9, Fc) Enterovirus D68 (EV-D68) (strain Fermon) VP4 Protein	Virus	Sf9 insect cells
	Enterovirus D68, a member of Enterovirus genus of the Picornaviridae family, mainly causes respiratory system-related diseases as well as neurological complications in some patients. The capsid of Enterovirus D68 virus is composed of subunit proteins (VP1, VP2, VP3, and VP4). VP1 protein contains multiple epitopes and receptor binding sites and is often used in phylogenetic analysis of viruses. Capsid protein VP4 is released, Capsid protein VP1 N-terminus is externalized, and together, they shape a pore in the host membrane through which the viral genome is translocated into the host cell cytoplasm. In addition, after binding to the host receptor, the capsid undergoes conformational changes. Enterovirus D68 VP4 Protein (sf9, Fc) is the recombinant Virus-derived Enterovirus D68 VP4 protein, expressed by Sf9 insect cells , with C-Rabbit Fc labeled tag.

HY-P75251

	Enterovirus D68 VP1 Protein (sf9, Fc) Enterovirus D68 (EV-D68) (strain Fermon) VP1 Protein	Virus	Sf9 insect cells
	Enterovirus D68, a member of Enterovirus genus of the Picornaviridae family, mainly causes respiratory system-related diseases as well as neurological complications in some patients. The capsid of Enterovirus D68 virus is composed of subunit proteins (VP1, VP2, VP3, and VP4). VP1 protein contains multiple epitopes and receptor binding sites and is often used in phylogenetic analysis of viruses. Capsid protein VP4 is released, Capsid protein VP1 N-terminus is externalized, and together, they shape a pore in the host membrane through which the viral genome is translocated into the host cell cytoplasm. In addition, after binding to the host receptor, the capsid undergoes conformational changes. Enterovirus D68 VP1 Protein (sf9, Fc) is the recombinant Virus-derived Enterovirus D68 VP1 protein, expressed by Sf9 insect cells , with C-hFc labeled tag.

HY-P76389

	Enterovirus 71 VP0 Protein (sf9, His-GST) Human Enterovirus 71 VP0 Protein (His-GST)	Virus	Sf9 insect cells
	The enterovirus 71 VP0 protein forms a 300 angstrom icosahedral capsid with the VP2 and VP3 proteins.Enterovirus 71 VP0 Protein (sf9, His-GST) is the recombinant Virus-derived Enterovirus 71 VP0 protein, expressed by Sf9 insect cells , with N-GST, N-His labeled tag.

HY-P704580

	Enterovirus 71 VP0 Protein (Sf9, His) Genome polyprotein; Human enterovirus 71 (strain USA/BrCr/1970) (EV71) (EV-71)	Virus	sf9 insect cells
	The enterovirus 71 VP0 protein forms a 300 angstrom icosahedral capsid with the VP2 and VP3 proteins. Enterovirus 71 VP0 Protein (Sf9, His) is the recombinant virus-derived Enterovirus 71 VP0 protein, expressed by sf9 insect cells, with N-His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-B0502S

Enrofloxacin-d5
Enrofloxacin-d₅ is the deuterium labeled Enrofloxacin. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-14805S

Tecovirimat-d4

Tecovirimat-d₄ (ST-246-d₄) is a deuterium-labelled Tecovirimat (HY-14805). Tecovirimat is an orally bioavailable and selective compound against orthopoxviruses [including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses]. Tecovirimat is evaluated against vaccinia, cowpox virus, ectromelia virus with EC₅₀ values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat targets the orthopoxvirus protein VP37 which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus. Tecovirimat could be used in the study for orthopoxvirus-induced diseases .

HY-W744243

Etoposide-d4
Etoposide-d₄ (VP-16-d₄; VP-16-213-d₄) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-13629S

Etoposide-d3
Etoposide-d3 (VP-16-d3) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-13629S1

Etoposide-13C,d3
Etoposide- ¹³C,d₃ is the ¹³C- and deuterium labeled Etoposide. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .

HY-B0502AS

Enrofloxacin-d5 hydrochloride
Enrofloxacin-d₅ (hydrochloride) is deuterium labeled Enrofloxacin (monohydrochloride). Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-B0502AS1

Enrofloxacin-d5 hydriodide
Enrofloxacin-d₅ (hydriodide) is the deuterium labeled Enrofloxacin (monohydrochloride). Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.

HY-19952S

Pleconaril-d4
Pleconaril-d₄ is deuterium labeled Pleconaril.

Host:	Mouse (6) Rabbit (1)
Reactivity:	Human (5) CPV (2)
Application:	IHC-P (5) ICC/IF (5) IP (1) WB (7) FC (5) ELISA (4)
Isotype:	IgG (3) IgG1 (4)
Conjugation:	Non-conjugated (7)
Clonality:	Monoclonal (4) Recombinant (1)
Modification:	Unmodified (4)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P86755

	CPV VP2 Antibody (YA6447) Capsid protein VP2; Coat protein VP2; Canine parvovirus;	WB	CPV
	CPV VP2 Antibody (YA6447) is a Mouse-derived and non-conjugated IgG monoclonal antibody, targeting to CPV VP2.

HY-P84921

	CPV-VP2 Antibody (YA4618) Canine Parvovirus VP2	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CPV-VP2 Antibody (YA4618) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CPV-VP2.

HY-P86755A

	CPV VP2 Antibody (YA6447)(PBS only) Capsid protein VP2; Coat protein VP2; Canine parvovirus;	WB	CPV
	CPV VP2 Antibody (YA6447) is a Mouse-derived and non-conjugated IgG monoclonal antibody, targeting to CPV VP2.

HY-P84921A

	CPV-VP2 Antibody (YA4618)(PBS only) Canine Parvovirus VP2	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CPV-VP2 Antibody (YA4618) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CPV-VP2.

HY-P84920

	VP2 Antibody (YA4617)	WB, IHC-P, ICC/IF, FC, ELISA	Human
	VP2 Antibody (YA4617) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to VP2.

HY-P84920A

	VP2 Antibody (YA4617)(PBS only)	WB, IHC-P, ICC/IF, FC, ELISA	Human
	VP2 Antibody (YA4617) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to VP2.

HY-P81675

	Nogo Antibody (YA1420) ASY; Foocen; NI220/250; NOGO; NOGOC; NSP; rat N; RTN X; Rtn4; RTN4-A; RTN4-B1; RTN4-B2; RTN4-C; VP20	WB, IHC-P, ICC/IF, FC, IP	Human
	Nogo Antibody (YA1420) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Nogo.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

VP

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Natural
Products